InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

HALOZYME THERAPEUTICS, INC.

HALO Clue Score50
United States Fiscal year ends December CIK 0001159036 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
Matthew L. Posard
1 Oct 2026
Director
Sold on a plan
100
$110.04
$11.00K
Matthew L. Posard
1 Oct 2026
Director
Sold on a plan
1,100
$109.57
$120.53K
Matthew L. Posard
1 Oct 2026
Director
Sold on a plan
3,300
$108.45
$357.90K
Matthew L. Posard
1 Oct 2026
Director
Sold on a plan
730
$107.17
$78.23K
Matthew L. Posard
16 Sep 2026
Director
Sold on a plan
4,000
$108.99
$435.96K
Matthew L. Posard
16 Sep 2026
Director
Sold on a plan
8,896
$108.04
$961.12K
Matthew L. Posard
16 Sep 2026
Director
Sold on a plan
3,000
$106.83
$320.48K
Matthew L. Posard
16 Sep 2026
Director
Sold on a plan
3,100
$106.13
$329.01K
Bernadette Connaughton
10 Aug 2026
Director
Sold on a plan
1,626
$102.80
$167.15K
Bernadette Connaughton
1 Jul 2026
Director
Sold on a plan
625
$77.21
$48.26K
Bernadette Connaughton
1 Jul 2026
Director
Sold on a plan
1,000
$76.40
$76.40K
Bernadette Connaughton
1 Jun 2026
Director
Sold on a plan
1,625
$66.21
$107.59K
Bernadette Connaughton
1 May 2026
Director
Sold on a plan
1,625
$63.48
$103.16K
Bernadette Connaughton
5 Jan 2026
Director
Sold on a plan
2,000
$70.25
$140.50K
Bernadette Connaughton
1 Dec 2025
Director
Sold on a plan
829
$71.60
$59.36K
Bernadette Connaughton
10 Nov 2025
Director
Sold on a plan
2,000
$68.48
$136.96K
Show all 105 transactions →

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 89
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 927,538
History held since 6 Dec 2006